3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
209
Observational
2
Sponsor
Cancer Type
Thoracic
10
Gastrointestinal
2
Head & Neck
1
Genitourinary
1
Dermatologic
1
Conditions
Unresectable Hepatocellular Carcinoma
1
Hepatobiliary Cancers
1
Interventions
Blood Specimen Collection
87
Surveys and Questionnaires
80
Surgical Procedures, Operative
53
Observation
44
Drug Therapy
44
Colonoscopy
41
Bevacizumab
41
Biopsy
35
Hepatectomy
33
Capecitabine
27
Neoadjuvant Therapy
26
Immune Checkpoint Inhibitors
26
regorafenib
25
Interviews as Topic
25
Radiotherapy
24
Oxaliplatin
24
Sorafenib
22
Magnetic Resonance Spectroscopy
22
lenvatinib
21
Endoscopic Mucosal Resection
21
Specimen Handling
18
Immunohistochemistry
18
Endoscopy
18
Pancreaticoduodenectomy
17
Liquid Biopsy
17
Gastrectomy
17
Endoscopic Ultrasound-Guided Fine Needle Aspiration
17
Tomography, X-Ray Computed
16
Gastroscopy
16
Fluorouracil
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
durvalumab
×
Gastrointestinal
×
Clear all
NCT06117891
2026-05-12
REFINE-IO
Bayer
Active not recruiting
300 enrolled
NCT06252753
2025-12-26
LIVER-R
AstraZeneca
Recruiting
4,490 enrolled